{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:12Z","timestamp":1793051892793,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:00:00Z","timestamp":1435017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12035-015-9230-2","type":"journal-article","created":{"date-parts":[[2015,6,21]],"date-time":"2015-06-21T21:47:30Z","timestamp":1434923250000},"page":"2619-2635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-\u03baB Pathways"],"prefix":"10.1007","volume":"53","author":[{"given":"Minhee","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik-Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,23]]},"reference":[{"key":"9230_CR1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano M, Galvan L, Deglon N, Brouillet E (2010) Mitochondria in Huntington's disease. Biochim Biophys Acta 1802:52\u201361","journal-title":"Biochim Biophys Acta"},{"key":"9230_CR2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1389450115666140115113734","volume":"15","author":"J Gil-Mohapel","year":"2014","unstructured":"Gil-Mohapel J, Brocardo PS, Christie BR (2014) The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates? Curr Drug Targets 15:454\u2013468","journal-title":"Curr Drug Targets"},{"key":"9230_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM et al (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 45:25\u201332","journal-title":"Ann Neurol"},{"key":"9230_CR4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"CM Chen","year":"2007","unstructured":"Chen CM, Wu YR, Cheng ML, Liu JL, Lee YM et al (2007) Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients. Biochem Biophys Res Commun 359:335\u2013340","journal-title":"Biochem Biophys Res Commun"},{"key":"9230_CR5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/hmg\/ddn033","volume":"17","author":"A Benchoua","year":"2008","unstructured":"Benchoua A, Trioulier Y, Diguet E, Malgorn C, Gaillard MC et al (2008) Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. Hum Mol Genet 17:1446\u20131456","journal-title":"Hum Mol Genet"},{"key":"9230_CR6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BST0351127","volume":"35","author":"ML Block","year":"2007","unstructured":"Block ML, Hong JS (2007) Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 35:1127\u20131132","journal-title":"Biochem Soc Trans"},{"key":"9230_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","volume":"114","author":"PO Fernagut","year":"2002","unstructured":"Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK et al (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation. Neuroscience 114:1005\u20131017","journal-title":"Neuroscience"},{"key":"9230_CR8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I Tunez","year":"2010","unstructured":"Tunez I, Tasset I, Perez-De La Cruz V, Santamaria A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules 15:878\u2013916","journal-title":"Molecules"},{"key":"9230_CR9","first-page":"237207","volume":"2013","author":"M Jang","year":"2013","unstructured":"Jang M, Lee MJ, Kim CS, Cho IH (2013) Korean red ginseng extract attenuates 3-nitropropionic acid-induced Huntington's-like symptoms. Evid Based Complement Alternat Med 2013:237207","journal-title":"Evid Based Complement Alternat Med"},{"key":"9230_CR10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2014.01.015","volume":"38","author":"M Jang","year":"2014","unstructured":"Jang M, Lee MJ, Cho IH (2014) Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms. Brain Behav Immun 38:151\u2013165","journal-title":"Brain Behav Immun"},{"key":"9230_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1139\/y2012-030","volume":"90","author":"GK Shinomol","year":"2012","unstructured":"Shinomol GK, Bharath MM, Muralidhara (2012) Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in the striatum of prepubertal mouse brain. Can J Physiol Pharmacol 90:595\u2013606","journal-title":"Can J Physiol Pharmacol"},{"key":"9230_CR12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Motohashi H, Yamamoto M (2013) Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34:340\u2013346","journal-title":"Trends Pharmacol Sci"},{"key":"9230_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-398339-8.00002-1","volume":"63","author":"IM Copple","year":"2012","unstructured":"Copple IM (2012) The Keap1-Nrf2 cell defense pathway\u2014a promising therapeutic target? Adv Pharmacol 63:43\u201379","journal-title":"Adv Pharmacol"},{"key":"9230_CR14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157488912803252023","volume":"7","author":"G Joshi","year":"2012","unstructured":"Joshi G, Johnson JA (2012) The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov 7:218\u2013229","journal-title":"Recent Pat CNS Drug Discov"},{"key":"9230_CR15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/nure.12060","volume":"71","author":"CA Houghton","year":"2013","unstructured":"Houghton CA, Fassett RG, Coombes JS (2013) Sulforaphane: translational research from laboratory bench to clinic. Nutr Rev 71:709\u2013726","journal-title":"Nutr Rev"},{"key":"9230_CR16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00018-007-6484-5","volume":"64","author":"N Juge","year":"2007","unstructured":"Juge N, Mithen RF, Traka M (2007) Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64:1105\u20131127","journal-title":"Cell Mol Life Sci"},{"key":"9230_CR17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1089\/neu.2011.1922","volume":"29","author":"X Wang","year":"2012","unstructured":"Wang X, de Rivero Vaccari JP, Wang H, Diaz P, German R et al (2012) Activation of the nuclear factor E2-related factor 2\/antioxidant response element pathway is neuroprotective after spinal cord injury. J Neurotrauma 29:936\u2013945","journal-title":"J Neurotrauma"},{"key":"9230_CR18","doi-asserted-by":"crossref","first-page":"415078","DOI":"10.1155\/2013\/415078","volume":"2013","author":"A Tarozzi","year":"2013","unstructured":"Tarozzi A, Angeloni C, Malaguti M, Morroni F, Hrelia S et al (2013) Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid Med Cell Longev 2013:415078","journal-title":"Oxid Med Cell Longev"},{"key":"9230_CR19","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1089\/neu.2012.2474","volume":"29","author":"AL Benedict","year":"2012","unstructured":"Benedict AL, Mountney A, Hurtado A, Bryan KE, Schnaar RL et al (2012) Neuroprotective effects of sulforaphane after contusive spinal cord injury. J Neurotrauma 29:2576\u20132586","journal-title":"J Neurotrauma"},{"key":"9230_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature11556","volume":"490","author":"SC Landis","year":"2012","unstructured":"Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R et al (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490:187\u2013191","journal-title":"Nature"},{"key":"9230_CR21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016172","volume":"6","author":"G Ellrichmann","year":"2011","unstructured":"Ellrichmann G, Petrasch-Parwez E, Lee DH, Reick C, Arning L et al (2011) Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington's disease. PLoS One 6, e16172","journal-title":"PLoS One"},{"key":"9230_CR22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R et al (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134:678\u2013692","journal-title":"Brain"},{"key":"9230_CR23","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1021\/cb4000103","volume":"8","author":"R Wang","year":"2013","unstructured":"Wang R, Mason DE, Choe KP, Lewin AS, Peters EC et al (2013) In vitro and in vivo characterization of a tunable dual-reactivity probe of the Nrf2-ARE pathway. ACS Chem Biol 8:1764\u20131774","journal-title":"ACS Chem Biol"},{"key":"9230_CR24","volume-title":"The mouse brain in stereotaxic coordinates; third, editor","author":"KBJ Franklin","year":"2008","unstructured":"Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates; third, editor. Elsevier Academic Press, San Iego"},{"key":"9230_CR25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","volume":"70","author":"E Brouillet","year":"1998","unstructured":"Brouillet E, Guyot MC, Mittoux V, Altairac S, Conde F et al (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794\u2013805","journal-title":"J Neurochem"},{"key":"9230_CR26","doi-asserted-by":"crossref","unstructured":"Lee MJ, Jang M, Choi J, Lee G, Min HJ, et al. (2015) Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses. Mol Neurobiol. doi: 10.1007\/s12035-014-9012-2","DOI":"10.1007\/s12035-014-9012-2"},{"key":"9230_CR27","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1093\/brain\/awn230","volume":"131","author":"IH Cho","year":"2008","unstructured":"Cho IH, Hong J, Suh EC, Kim JH, Lee H et al (2008) Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain 131:3019\u20133033","journal-title":"Brain"},{"key":"9230_CR28","doi-asserted-by":"crossref","first-page":"39447","DOI":"10.1074\/jbc.M110.132522","volume":"285","author":"J Hong","year":"2010","unstructured":"Hong J, Cho IH, Kwak KI, Suh EC, Seo J et al (2010) Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J Biol Chem 285:39447\u201339457","journal-title":"J Biol Chem"},{"key":"9230_CR29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"9230_CR30","doi-asserted-by":"crossref","unstructured":"Brouillet E (2014) The 3-NP Model of Striatal Neurodegeneration. Curr Protoc Neurosci. 67:9.48.1-9.48.14. doi: 10.1002\/0471142301.ns0948s67","DOI":"10.1002\/0471142301.ns0948s67"},{"key":"9230_CR31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/exnr.2002.7933","volume":"176","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu A, Ferrante RJ, Andreassen OA, Dillmann WH, Beal MF (2002) Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid. Exp Neurol 176:262\u2013265","journal-title":"Exp Neurol"},{"key":"9230_CR32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","volume":"10","author":"CS Lobsiger","year":"2007","unstructured":"Lobsiger CS, Cleveland DW (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10:1355\u20131360","journal-title":"Nat Neurosci"},{"key":"9230_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.phrs.2013.07.010","volume":"76","author":"R Foresti","year":"2013","unstructured":"Foresti R, Bains SK, Pitchumony TS, de Castro Bras LE, Drago F et al (2013) Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. Pharmacol Res 76:132\u2013148","journal-title":"Pharmacol Res"},{"key":"9230_CR34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","volume":"181","author":"NG Innamorato","year":"2008","unstructured":"Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, de Ceballos ML et al (2008) The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181:680\u2013689","journal-title":"J Immunol"},{"key":"9230_CR35","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1073\/pnas.1009926107","volume":"107","author":"D Kim","year":"2010","unstructured":"Kim D, You B, Jo EK, Han SK, Simon MI et al (2010) NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc Natl Acad Sci U S A 107:14851\u201314856","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9230_CR36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-009-0116-5","volume":"59","author":"LO Brandenburg","year":"2010","unstructured":"Brandenburg LO, Kipp M, Lucius R, Pufe T, Wruck CJ (2010) Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm Res 59:443\u2013450","journal-title":"Inflamm Res"},{"key":"9230_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbrc.2009.01.082","volume":"380","author":"K Koh","year":"2009","unstructured":"Koh K, Cha Y, Kim S, Kim J (2009) tBHQ inhibits LPS-induced microglial activation via Nrf2-mediated suppression of p38 phosphorylation. Biochem Biophys Res Commun 380:449\u2013453","journal-title":"Biochem Biophys Res Commun"},{"key":"9230_CR38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/156720211798120972","volume":"8","author":"G Negi","year":"2011","unstructured":"Negi G, Kumar A, Sharma SS (2011) Nrf2 and NF-kappaB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr Neurovasc Res 8:294\u2013304","journal-title":"Curr Neurovasc Res"},{"key":"9230_CR39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","volume":"33","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 33:100\u2013108","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9230_CR40","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1523\/JNEUROSCI.2238-14.2014","volume":"34","author":"Q Wang","year":"2014","unstructured":"Wang Q, Chu CH, Qian L, Chen SH, Wilson B et al (2014) Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase. J Neurosci 34:12490\u201312503","journal-title":"J Neurosci"},{"key":"9230_CR41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2014.04.014","volume":"73","author":"A Kumar","year":"2014","unstructured":"Kumar A, Chen SH, Kadiiska MB, Hong JS, Zielonka J et al (2014) Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells. Free Radic Biol Med 73:51\u201359","journal-title":"Free Radic Biol Med"},{"key":"9230_CR42","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F et al (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66:1638\u20131643","journal-title":"Neurology"},{"key":"9230_CR43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/10715762.2014.936432","volume":"48","author":"Y Gao","year":"2014","unstructured":"Gao Y, Chu SF, Li JP, Zuo W, Wen ZL et al (2014) Do glial cells play an anti-oxidative role in Huntington's disease? Free Radic Res 48:1135\u20131144","journal-title":"Free Radic Res"},{"key":"9230_CR44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2199-9-84","volume":"9","author":"WM Roon-Mom van","year":"2008","unstructured":"van Roon-Mom WM, Pepers BA, t Hoen PA, Verwijmeren CA, den Dunnen JT et al (2008) Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease. BMC Mol Biol 9:84","journal-title":"BMC Mol Biol"},{"key":"9230_CR45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","volume":"49","author":"C Stack","year":"2010","unstructured":"Stack C, Ho D, Wille E, Calingasan NY, Williams C et al (2010) Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radic Biol Med 49:147\u2013158","journal-title":"Free Radic Biol Med"},{"key":"9230_CR46","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","volume":"29","author":"EJ Wild","year":"2014","unstructured":"Wild EJ, Tabrizi SJ (2014) Targets for future clinical trials in Huntington's disease: what's in the pipeline? Mov Disord 29:1434\u20131445","journal-title":"Mov Disord"},{"key":"9230_CR47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14728222.7.2.187","volume":"7","author":"SJ Harper","year":"2003","unstructured":"Harper SJ, Wilkie N (2003) MAPKs: new targets for neurodegeneration. Expert Opin Ther Targets 7:187\u2013200","journal-title":"Expert Opin Ther Targets"},{"key":"9230_CR48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3940(99)00906-4","volume":"278","author":"T Sugino","year":"2000","unstructured":"Sugino T, Nozaki K, Hashimoto N (2000) Activation of mitogen-activated protein kinases in gerbil hippocampus with ischemic tolerance induced by 3-nitropropionic acid. Neurosci Lett 278:101\u2013104","journal-title":"Neurosci Lett"},{"key":"9230_CR49","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1074\/jbc.C000180200","volume":"275","author":"YF Liu","year":"2000","unstructured":"Liu YF, Dorow D, Marshall J (2000) Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin. J Biol Chem 275:19035\u201319040","journal-title":"J Biol Chem"},{"key":"9230_CR50","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s10753-014-9875-4","volume":"37","author":"YJ Choi","year":"2014","unstructured":"Choi YJ, Lee WS, Lee EG, Sung MS, Yoo WH (2014) Sulforaphane inhibits IL-1beta-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of MMPs, COX-2, and PGE2. Inflammation 37:1496\u20131503","journal-title":"Inflammation"},{"key":"9230_CR51","first-page":"1083","volume":"13","author":"LP Yang","year":"2007","unstructured":"Yang LP, Zhu XA, Tso MO (2007) Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation. Mol Vis 13:1083\u20131093","journal-title":"Mol Vis"},{"key":"9230_CR52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0047-6374(03)00083-6","volume":"124","author":"CC Hsieh","year":"2003","unstructured":"Hsieh CC, Rosenblatt JI, Papaconstantinou J (2003) Age-associated changes in SAPK\/JNK and p38 MAPK signaling in response to the generation of ROS by 3-nitropropionic acid. Mech Ageing Dev 124:733\u2013746","journal-title":"Mech Ageing Dev"},{"key":"9230_CR53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/MCB.17.1.24","volume":"17","author":"P Juo","year":"1997","unstructured":"Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J et al (1997) Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE\/CED-3 family proteases. Mol Cell Biol 17:24\u201335","journal-title":"Mol Cell Biol"},{"key":"9230_CR54","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","volume":"322","author":"I Bezprozvanny","year":"2004","unstructured":"Bezprozvanny I, Hayden MR (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun 322:1310\u20131317","journal-title":"Biochem Biophys Res Commun"},{"key":"9230_CR55","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1167\/iovs.06-0871","volume":"48","author":"LP Yang","year":"2007","unstructured":"Yang LP, Zhu XA, Tso MO (2007) Role of NF-kappaB and MAPKs in light-induced photoreceptor apoptosis. Invest Ophthalmol Vis Sci 48:4766\u20134776","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9230_CR56","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","volume":"24","author":"A Khoshnan","year":"2004","unstructured":"Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH et al (2004) Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci 24:7999\u20138008","journal-title":"J Neurosci"},{"key":"9230_CR57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","volume":"164","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kalonia H, Kumar A (2011) Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164:644\u2013654","journal-title":"Br J Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9230-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9230-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:42:21Z","timestamp":1559428941000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9230-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,23]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["9230"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9230-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,23]]}}}